


Symbiotic.blue Revenue
Hospitals and Health Care • • 1-10 Employees
Symbiotic.blue revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Hospitals and Health Care industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at Symbiotic.blue
Kam Pooni
Co-Founder and CEO
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 923 |
| Keywords | Obesity, Pharmaceutical, Biotech, Drug Discovery, Data Science, Bioinformatics, Translational Medicine, Precision Medicine, Deep Learning, Biomarker Discovery, Computational Biology, Artificial Intelligence (Ai), Target Identification, Lifesciences, Molecular Modeling, Chemoinformatics, Glp-1, Machine Learning (Ml), High-Throughput Screening (Hts), Techbio, Healthcare Ai, Omics Data Analysis (Genomics, Proteomics), Structure-Based Drug Design (Sbdd) |
| Employees | 1-10 |
| Socials |
About Symbiotic.blue
Symbiotic.blue, a newly launched UK techbio venture, is developing a next-generation artificial intelligence-driven drug discovery (AIDD) platform. By enhancing generative AI with neuroscience-inspired methodologies, the company aims to create smarter, multi-targeted therapeutics to tackle complex diseases, beginning with obesity. Founded by a team of seasoned life sciences entrepreneurs and world-renowned academics from the Universities of Oxford and Cambridge, Symbiotic.blue is currently raising a pre-seed round to build its proprietary platform and initiate early-stage discovery programs.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Symbiotic.blue has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Symbiotic.blue has never raised funding before.
Frequently asked questions
4.8
40,000 users



